David E. Bush, Ph.D. - Publications

Affiliations: 
2004 University of Toronto, Toronto, ON, Canada 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Bush DE, Vaccarino FJ. Individual differences in elevated plus-maze exploration predicted progressive-ratio cocaine self-administration break points in Wistar rats. Psychopharmacology. 194: 211-9. PMID 17581743 DOI: 10.1007/s00213-007-0835-7  0.488
2004 Wunderlich GR, Rotzinger S, Bush DE, DeSousa NJ, Vaccarino FJ. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure. Brain Research. 1001: 95-107. PMID 14972658 DOI: 10.1016/J.Brainres.2003.10.064  0.482
2002 Rotzinger S, Bush DE, Vaccarino FJ. Cholecystokinin modulation of mesolimbic dopamine function: regulation of motivated behaviour. Pharmacology & Toxicology. 91: 404-13. PMID 12688386 DOI: 10.1034/J.1600-0773.2002.910620.X  0.474
2001 Parent M, Bush D, Rauw G, Master S, Vaccarino F, Baker G. Analysis of amino acids and catecholamines, 5-hydroxytryptamine and their metabolites in brain areas in the rat using in vivo microdialysis. Methods (San Diego, Calif.). 23: 11-20. PMID 11162146 DOI: 10.1006/Meth.2000.1102  0.413
2000 DeSousa NJ, Bush DE, Vaccarino FJ. Self-administration of intravenous amphetamine is predicted by individual differences in sucrose feeding in rats. Psychopharmacology. 148: 52-8. PMID 10663417  0.516
1999 Bush DE, DeSousa NJ, Vaccarino FJ. Self-administration of intravenous amphetamine: effect of nucleus accumbens CCKB receptor activation on fixed-ratio responding. Psychopharmacology. 147: 331-4. PMID 10639694 DOI: 10.1007/s002130051176  0.525
1995 Josselyn SA, Frankland PW, Petrisano S, Bush DE, Yeomans JS, Vaccarino FJ. The CCKB antagonist, L-365,260, attenuates fear-potentiated startle. Peptides. 16: 1313-5. PMID 8545257 DOI: 10.1016/0196-9781(95)02013-M  0.445
Show low-probability matches.